Name | Budigalimab |
---|
Description | Budigalimab (ABBV 181; PR 1648817) is a humanized IgG1 monoclonal antibody targeting programmed cell death 1 (PD-1) receptor. Budigalimab is Fc mutated thus to reduce Fc receptor interactions and limit effector function[1]. |
---|---|
Related Catalog | |
Target |
programmed cell death 1 (PD-1) receptor[1] |
References |
No Any Chemical & Physical Properties |